Please use this identifier to cite or link to this item:
|Title:||Cancer proteomics||Authors:||Tan, H.T.
quantitative proteomics strategies
|Issue Date:||Sep-2012||Citation:||Tan, H.T., Lee, Y.H., Chung, M.C.M. (2012-09). Cancer proteomics. Mass Spectrometry Reviews 31 (5) : 583-605. ScholarBank@NUS Repository. https://doi.org/10.1002/mas.20356||Abstract:||Cancer presents high mortality and morbidity globally, largely due to its complex and heterogenous nature, and lack of biomarkers for early diagnosis. A proteomics study of cancer aims to identify and characterize functional proteins that drive the transformation of malignancy, and to discover biomarkers to detect early-stage cancer, predict prognosis, determine therapy efficacy, identify novel drug targets, and ultimately develop personalized medicine. The various sources of human samples such as cell lines, tissues, and plasma/serum are probed by a plethora of proteomics tools to discover novel biomarkers and elucidate mechanisms of tumorigenesis. Innovative proteomics technologies and strategies have been designed for protein identification, quantitation, fractionation, and enrichment to delve deeper into the oncoproteome. In addition, there is the need for high-throughput methods for biomarker validation, and integration of the various platforms of oncoproteome data to fully comprehend cancer biology. © 2012 Wiley Periodicals, Inc. Mass Spec Rev 31:583-605, 2012 Copyright © 2012 Wiley Periodicals, Inc.||Source Title:||Mass Spectrometry Reviews||URI:||http://scholarbank.nus.edu.sg/handle/10635/109222||ISSN:||02777037||DOI:||10.1002/mas.20356|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Oct 16, 2019
WEB OF SCIENCETM
checked on Oct 9, 2019
checked on Oct 11, 2019
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.